InvestorsHub Logo

jour_trader

03/26/21 3:57 PM

#353422 RE: NASDAQ2020 #353421

I’m sure Loxapine competitors are freaking out.

alexander77

03/27/21 4:47 AM

#353430 RE: NASDAQ2020 #353421

Three consecutive quarters of net profitability. If I were a CEO I would certainly not do a buy back of shares. What would be the use of that in heavens' sake! I am sure that if the company shows net profitability the next quarter, the share price will be at $0.2/share. As a CEO I would continue accumulating profits. With the continuous money inflow I would update my manufacturing facility and make production contracts with other pharmaceutical companies, and look for takeover/merger possibilities.

In the COVID19 period Elite is one of the few companies showing profitability, they are in a great position. Generics are the future.